Literature DB >> 28802862

MicroRNA-21: Expression in oligodendrocytes and correlation with low myelin mRNAs in depression and alcoholism.

José Javier Miguel-Hidalgo1, Katherine O Hall2, Hannah Bonner2, Anna M Roller2, Maryam Syed3, Casey J Park3, Jana P Ball3, Marc E Rothenberg4, Craig A Stockmeier2, Damian G Romero3.   

Abstract

MiR-21 is a microRNA implicated in cancer, development, and cardiovascular diseases and expressed in the central nervous system (CNS), especially after injury. However, the cellular expression of miR-21 in the adult CNS has not been clearly established either in mice or human subjects, while its alteration in psychiatric disorders is unknown. MiR-21 expression was characterized in reporter mice expressing β-galactosidase (LacZ) under the endogenous miR-21 promoter (miR-21/LacZ). Brain co-localization of miR-21/LacZ with specific neural markers was examined by double immunofluorescence in reporter mice, while extent of immunostaining for myelin basic protein and PDGFRα was determined in miR-21 knockout and wild-type mice. Levels of miR-21, and mRNAs of selected miR-21 targets, miR-21 regulator STAT3 and myelin-related proteins were measured by qRT-PCR in the white matter (WM) adjacent to the left postmortem orbitofrontal cortex (OFC) of human subjects with major depressive disorder (MDD), alcoholism, comorbid MDD plus alcoholism (MDA) and non-psychiatric control subjects. MiR-21/LacZ was highly expressed in cell bodies of WM and myelinated portions of gray matter (GM). Labeled cell bodies were identified as oligodendrocytes, while miR-21/LacZ was barely detectable in other cell types. MiR-21, as well as the mRNAs of several myelin-related proteins, were reduced in the WM of subjects with MDD and alcoholism. MiR-21 positively correlated with mRNA of myelin-related proteins and astrocytic GFAP. High expression of miR-21 in adult oligodendrocytes and the correlation of miR-21 decrease with mRNA of some myelin proteins, regulator STAT3, and oligodendrocyte-related transcription factors suggest an involvement of miR-21 in WM alterations in depression and alcoholism.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocytes; Glia; Human; Knockout; Mouse; Postmortem; Prefrontal; mRNA; miR-21

Mesh:

Substances:

Year:  2017        PMID: 28802862      PMCID: PMC5610939          DOI: 10.1016/j.pnpbp.2017.08.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  67 in total

1.  A microRNA array reveals extensive regulation of microRNAs during brain development.

Authors:  Anna M Krichevsky; Kevin S King; Christine P Donahue; Konstantin Khrapko; Kenneth S Kosik
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

2.  On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immunohistochemistry of connexin43 expression.

Authors:  T Yamamoto; A Ochalski; E L Hertzberg; J I Nagy
Journal:  J Comp Neurol       Date:  1990-12-22       Impact factor: 3.215

3.  Expression of MBP, PLP, MAG, CNP, and GFAP in the Human Alcoholic Brain.

Authors:  Joanne M Lewohl; Julie Wixey; Clive G Harper; Peter R Dodd
Journal:  Alcohol Clin Exp Res       Date:  2005-09       Impact factor: 3.455

Review 4.  White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies.

Authors:  Ming Wei Tham; Puay San Woon; Min Yi Sum; Tih-Shih Lee; Kang Sim
Journal:  J Affect Disord       Date:  2010-10-02       Impact factor: 4.839

Review 5.  Molecular mechanisms of gap junction mutations in myelinating cells.

Authors:  Irene Sargiannidou; Kyriaki Markoullis; Kleopas A Kleopa
Journal:  Histol Histopathol       Date:  2010-09       Impact factor: 2.303

6.  Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Authors:  Jose J Miguel-Hidalgo; Angela Whittom; Ashley Villarreal; Madhav Soni; Ashish Meshram; Jason C Pickett; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

7.  SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function.

Authors:  C Claus Stolt; Anita Schlierf; Petra Lommes; Simone Hillgärtner; Torsten Werner; Thomas Kosian; Elisabeth Sock; Nicoletta Kessaris; William D Richardson; Veronique Lefebvre; Michael Wegner
Journal:  Dev Cell       Date:  2006-11       Impact factor: 12.270

8.  Neurocircuitry of emotion and cognition in alcoholism: contributions from white matter fiber tractography.

Authors:  Tilman Schulte; Eva M Mũller-Oehring; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.

Authors:  Hesheng Ou; Yumei Li; Min Kang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

10.  Dicer ablation in oligodendrocytes provokes neuronal impairment in mice.

Authors:  Daesung Shin; Ji-Yeon Shin; Michael T McManus; Louis J Ptácek; Ying-Hui Fu
Journal:  Ann Neurol       Date:  2009-12       Impact factor: 10.422

View more
  14 in total

Review 1.  Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Authors:  Yousef Tizabi; Bruk Getachew; Clifford L Ferguson; Antonei B Csoka; Karl M Thompson; Alejandra Gomez-Paz; Jana Ruda-Kucerova; Robert E Taylor
Journal:  Neurotox Res       Date:  2018-01-04       Impact factor: 3.911

2.  Glucocorticoid-Induced Reductions of Myelination and Connexin 43 in Mixed Central Nervous System Cell Cultures Are Prevented by Mifepristone.

Authors:  José Javier Miguel-Hidalgo; Kathleen Carter; Preston Hardin Deloach; Leon Sanders; Yi Pang
Journal:  Neuroscience       Date:  2019-06-01       Impact factor: 3.590

3.  Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.

Authors:  Gouri J Mahajan; Eric J Vallender; Michael R Garrett; Lavanya Challagundla; James C Overholser; George Jurjus; Lesa Dieter; Maryam Syed; Damian G Romero; Hamed Benghuzzi; Craig A Stockmeier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-11-22       Impact factor: 5.067

4.  The Effect of Chronic Ethanol Exposure and Thiamine Deficiency on Myelin-related Genes in the Cortex and the Cerebellum.

Authors:  Bradley J Chatterton; Polliana T Nunes; Lisa M Savage
Journal:  Alcohol Clin Exp Res       Date:  2020-11-24       Impact factor: 3.455

5.  Astrocyte pathology in the ventral prefrontal white matter in depression.

Authors:  Grazyna Rajkowska; Beata Legutko; Mohadetheh Moulana; Maryam Syed; Damian G Romero; Craig A Stockmeier; Jose Javier Miguel-Hidalgo
Journal:  J Psychiatr Res       Date:  2018-04-07       Impact factor: 4.791

Review 6.  Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression.

Authors:  José Javier Miguel-Hidalgo
Journal:  Front Cell Neurosci       Date:  2022-04-22       Impact factor: 6.147

7.  Multi-modal imaging reveals differential brain volumetric, biochemical, and white matter fiber responsivity to repeated intermittent ethanol vapor exposure in male and female rats.

Authors:  Natalie M Zahr; Aran M Lenart; Joshua A Karpf; Keriann M Casey; Kilian M Pohl; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropharmacology       Date:  2020-03-30       Impact factor: 5.250

Review 8.  The important roles of microRNAs in depression: new research progress and future prospects.

Authors:  Chenggui Miao; Jun Chang
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

9.  Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma.

Authors:  Yongfang Xie; Ling Wang; Zengyan Xie; Chuisheng Zeng; Kunxian Shu
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

Review 10.  Molecular Neuropathology of Astrocytes and Oligodendrocytes in Alcohol Use Disorders.

Authors:  José J Miguel-Hidalgo
Journal:  Front Mol Neurosci       Date:  2018-03-20       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.